RA Capital Management, L.P. 13D/13G Filings for Talaris Therapeutics, Inc. (TALS)

RA Capital Management, L.P. 13D and 13G filings for Talaris Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-07-06
4:32 pm
Purchase
2023-06-26 13G Talaris Therapeutics, Inc.
TALS
RA Capital Management, L.P. 233,318
5.500%
233,318increase
(New Position)
Filing